Mani Chidambaram
Role not yet determined Is this you? Add your title
Also affiliated: United States Food and Drug Administration (2015–2023)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Mani Chidambaram's research focuses on evaluating the toxicological effects of various chemical compounds, particularly bisphenol A (BPA), in animal models. His work includes studies on the administration of BPA to Sprague Dawley rats from gestation through postnatal development, investigating its toxicity over extended periods. Chidambaram has also explored the placental transfer and pharmacokinetics of drugs in pregnant rats, utilizing a microphysiological human placental barrier model to assess drug transfer. His research contributes to understanding the potential health impacts of environmental exposures and the behavior of pharmaceuticals during pregnancy. His work has resulted in six publications, accumulating 285 citations, and he holds an h-index of 5. He has collaborated with researchers at the National Center for Toxicological Research, including Matthew Bryant and Darshan Mehta.
Metrics
- h-index: 5
- Publications: 6
- Citations: 286
Selected Publications
-
Evaluation of a microphysiological human placental barrier model for studying placental drug transfer (2023)
-
In vivo pharmacokinetic analyses of placental transfer of three drugs of different physicochemical properties in pregnant rats (2022)
-
NIEHS/FDA CLARITY-BPA research program update (2015)
-
Toxicity Evaluation of Bisphenol A Administered by Gavage to Sprague Dawley Rats From Gestation Day 6 Through Postnatal Day 90 (2014)
Collaboration Network
Top Collaborators
- Toxicity Evaluation of Bisphenol A Administered by Gavage to Sprague Dawley Rats From Gestation Day 6 Through Postnatal Day 90
- NIEHS/FDA CLARITY-BPA research program update
- In vivo pharmacokinetic analyses of placental transfer of three drugs of different physicochemical properties in pregnant rats
- Evaluation of a microphysiological human placental barrier model for studying placental drug transfer
- Toxicity Evaluation of Bisphenol A Administered by Gavage to Sprague Dawley Rats From Gestation Day 6 Through Postnatal Day 90
- NIEHS/FDA CLARITY-BPA research program update
- Toxicity Evaluation of Bisphenol A Administered by Gavage to Sprague Dawley Rats From Gestation Day 6 Through Postnatal Day 90
- NIEHS/FDA CLARITY-BPA research program update
- Toxicity Evaluation of Bisphenol A Administered by Gavage to Sprague Dawley Rats From Gestation Day 6 Through Postnatal Day 90
- NIEHS/FDA CLARITY-BPA research program update
- Toxicity Evaluation of Bisphenol A Administered by Gavage to Sprague Dawley Rats From Gestation Day 6 Through Postnatal Day 90
- NIEHS/FDA CLARITY-BPA research program update
- Toxicity Evaluation of Bisphenol A Administered by Gavage to Sprague Dawley Rats From Gestation Day 6 Through Postnatal Day 90
- NIEHS/FDA CLARITY-BPA research program update
- In vivo pharmacokinetic analyses of placental transfer of three drugs of different physicochemical properties in pregnant rats
- Evaluation of a microphysiological human placental barrier model for studying placental drug transfer
- In vivo pharmacokinetic analyses of placental transfer of three drugs of different physicochemical properties in pregnant rats
- Evaluation of a microphysiological human placental barrier model for studying placental drug transfer
- NIEHS/FDA CLARITY-BPA research program update
- NIEHS/FDA CLARITY-BPA research program update
- NIEHS/FDA CLARITY-BPA research program update
- NIEHS/FDA CLARITY-BPA research program update
- NIEHS/FDA CLARITY-BPA research program update
- NIEHS/FDA CLARITY-BPA research program update
- NIEHS/FDA CLARITY-BPA research program update
Similar Researchers
Based on overlapping research topics